Health Center: Menactra

The U.S. Food and Drug Administration (FDA) recently approved a new quadrivalent conjugate vaccine (Menactra™) for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, W-135. Meningococcal disease is a serious bacterial infection. It can cause meningitis—severe swelling of the brain and spinal cord. It can also lead to sepsis—a dangerous and potentially life-threatening blood infection.

For more information, visit the American College Health Association website http://www.acha.org/projects_programs/meningitis/index.cfm and the CDC website: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/meningococcal_g.htm